The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Relation between urinary androgen and corticoid excretion and subsequent breast cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Epidemiological studies have generally observed a protective effect of DHEA on breast cancer, especially in Western women (191,193,281,282).”
From Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone (2003) · cites this paper as [191]
Citations
Cites
ŒSTROGEN FRACTIONS DURING EARLY REPRODUCTIVE LIFE IN THE ÆTIOLOGY OF BREAST CANCER
Cole, P. T., & MacMahon, B. (1969) · The Lancet · doi:10.1016/s0140-6736(69)91537-2 · Cited by 171
ABNORMAL URINARY STEROID EXCRETION AND SUBSEQUENT BREAST CANCER
Bulbrook, R. D., & Hayward, J. L. (1967) · The Lancet · doi:10.1016/s0140-6736(67)92107-1 · Cited by 117
Self-citationAbnormal excretion of urinary steroids by women with early breast cancer.
Bulbrook, R. D., Hayward, J. L., Spicer, C. C., & Thomas, B. S. (1962) · The Lancet · doi:10.1016/s0140-6736(62)92812-x · Cited by 105
Self-citationBulbrook, R. D., Hayward, J. L., Spicer, C. C., & Thomas, B. S. (1962) · The Lancet · doi:10.1016/s0140-6736(62)92811-8 · Cited by 89
Self-citationHormone Excretion Patterns in Breast and Prostate Cancer Are Abnormal
Stern, E., Hopkins, C. E., Weiner, J. M., & Marmorston, J. (1964) · Science · doi:10.1126/science.145.3633.716 · Cited by 46
Benign and malignant breast disease in south Wales: a study of urinary steroids.
Cameron, E. H. D., Griffiths, K., Gleave, E. N., Stewart, H. J., Forrest, A. P. M., & Campbell, H. (1970) · BMJ · doi:10.1136/bmj.4.5738.768 · Cited by 38
Wang, D. Y., Bulbrook, R. D., Thomas, B. S., & Friedman, M. (1968) · Journal of Endocrinology · doi:10.1677/joe.0.0420567 · Cited by 31
Self-citationTHE DISCRIMINANT FUNCTION IN EARLY CARCINOMA OF THE BREAST
Wade, A. P., Davis, J. C., Tweedie, M. C. K., Clarke, C. A., & Haggart, B. G. (1969) · The Lancet · doi:10.1016/s0140-6736(69)91899-6 · Cited by 29
Adams, J. B., & Wong, M. S. F. (1968) · The Lancet · doi:10.1016/s0140-6736(68)91640-1 · Cited by 16
The value of urine steroid hormone assays in breastcancer
Miller, H., & Durant, J. A. (1967) · Clinical Biochemistry · doi:10.1016/s0009-9120(67)80034-1 · Cited by 13
Research works printed but not linked: 2
- Bacigalupo, 1968, Arch. Geschwulstforsch., 32, 95
- Nabarro, 1960, Lancet, i, 1292
Cited by
Sorted by citations
ORENTREICH, N., BRIND, J. L., RIZER, R. L., & VOGELMAN, J. H. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-59-3-551 · Cited by 1,349
Differentiation of the mammary gland and susceptibility to carcinogenesis
Russo, J., Tay, L. K., & Russo, I. H. (1982) · Breast Cancer Research and Treatment · doi:10.1007/bf01805718 · Cited by 619
Labrie, F., Luu-The, V., Labrie, C., Bélanger, A., Simard, J., Lin, S.-X., & Pelletier, G. (2003) · Endocrine Reviews · doi:10.1210/er.2001-0031 · Cited by 544
Hormones and the physiological architecture of life history evolution
Finch, C. E., & Rose, M. R. (1995) · The Quarterly Review of Biology · doi:10.1086/418864 · Cited by 376
Serum Sex Hormone Levels After Menopause and Subsequent Breast Cancer
Berrino, F., Muti, P. C., Micheli, A., BOLELLI, G., Krogh, V., Sciajno, R., Pisani, P., Panico, S., & Secreto, G. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.5.291 · Cited by 335
Metadata
- Authors
- Bulbrook, R. D., Hayward, J. L., & Spicer, C. C.
- Affiliations
- Guy's Hospital (GB)
- Medical Research Council (GB)
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 1971-08
- Volume
- 298
- Issue
- 7721
- Pages
- 395-398
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2054644728
- Cited by
- 221
- References
- 10
- Citations by year
- 2026: 1 · 2020: 2 · 2018: 1 · 2014: 1
- FWCI
- 11.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Oncology › Cancer Risks and Factors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- breast cancer, urinary androgens, androsterone, etiocholanolone, corticosteroids, androgen metabolites, breast cancer screening, women, premenopausal women
- MeSH terms
- Adrenal Cortex Hormones, Adult, Age Factors, Androgens, Body Height, Body Weight, Breast Neoplasms, Etiocholanolone, Female, United Kingdom, Humans, Middle Aged, Parity, Precancerous Conditions, Time Factors, 17-Hydroxycorticosteroids
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
